Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Illumina Inc. (NASDAQ:ILMN)

Analysis of Profitability Ratios

Beginner level

Profitability Ratios (Summary)

Illumina Inc., profitability ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 29, 2019 Dec 30, 2018 Dec 31, 2017 Dec 31, 2016
Return on Sales
Gross profit margin 68.01% 69.63% 69.01% 66.35% 69.48%
Operating profit margin 17.91% 27.80% 26.49% 22.02% 24.48%
Net profit margin 20.25% 28.28% 24.78% 26.38% 19.29%
Return on Investment
Return on equity (ROE) 13.98% 21.72% 21.98% 26.41% 21.06%
Return on assets (ROA) 8.65% 13.70% 11.87% 13.81% 10.81%

Based on: 10-K (filing date: 2021-02-17), 10-K (filing date: 2020-02-11), 10-K (filing date: 2019-02-12), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-14).

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Illumina Inc.’s gross profit margin ratio improved from 2018 to 2019 but then deteriorated significantly from 2019 to 2020.
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Illumina Inc.’s operating profit margin ratio improved from 2018 to 2019 but then deteriorated significantly from 2019 to 2020.
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Illumina Inc.’s net profit margin ratio improved from 2018 to 2019 but then deteriorated significantly from 2019 to 2020.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. Illumina Inc.’s ROE deteriorated from 2018 to 2019 and from 2019 to 2020.
ROA A profitability ratio calculated as net income divided by total assets. Illumina Inc.’s ROA improved from 2018 to 2019 but then deteriorated significantly from 2019 to 2020.

Gross Profit Margin

Illumina Inc., gross profit margin calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 29, 2019 Dec 30, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in millions)
Gross profit 2,203  2,467  2,300  1,826  1,666 
Revenue 3,239  3,543  3,333  2,752  2,398 
Profitability Ratio
Gross profit margin1 68.01% 69.63% 69.01% 66.35% 69.48%
Benchmarks
Gross Profit Margin, Competitors2
AbbVie Inc. 66.41% 77.64% 76.44% 75.05% 77.25%
Amgen Inc. 74.59% 80.38% 81.80% 81.33% 80.99%
Eli Lilly & Co. 77.66% 78.85% 73.81% 73.46% 73.35%
Gilead Sciences Inc. 81.23% 78.86% 77.61% 82.97% 85.77%
Johnson & Johnson 65.58% 66.42% 66.79% 66.84% 69.84%
Merck & Co. Inc. 67.74% 69.87% 68.06% 68.16% 65.10%
Pfizer Inc. 79.26% 80.25% 79.03% 78.61% 76.66%
Regeneron Pharmaceuticals Inc. 86.82% 90.05% 93.53% 93.24% 93.83%
Thermo Fisher Scientific Inc. 49.67% 44.35% 44.57% 45.15% 45.80%
Zoetis Inc. 69.18% 68.18% 67.19% 66.55% 65.92%

Based on: 10-K (filing date: 2021-02-17), 10-K (filing date: 2020-02-11), 10-K (filing date: 2019-02-12), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-14).

1 2020 Calculation
Gross profit margin = 100 × Gross profit ÷ Revenue
= 100 × 2,203 ÷ 3,239 = 68.01%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Illumina Inc.’s gross profit margin ratio improved from 2018 to 2019 but then deteriorated significantly from 2019 to 2020.

Operating Profit Margin

Illumina Inc., operating profit margin calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 29, 2019 Dec 30, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in millions)
Income from operations 580  985  883  606  587 
Revenue 3,239  3,543  3,333  2,752  2,398 
Profitability Ratio
Operating profit margin1 17.91% 27.80% 26.49% 22.02% 24.48%
Benchmarks
Operating Profit Margin, Competitors2
AbbVie Inc. 24.81% 39.03% 19.49% 33.99% 36.60%
Amgen Inc. 37.70% 43.57% 45.55% 45.76% 44.74%
Eli Lilly & Co. 24.69% 22.29% 15.15% 9.38% 16.30%
Gilead Sciences Inc. 16.72% 19.38% 37.83% 55.04% 58.87%
Johnson & Johnson 23.60% 24.15% 24.27% 24.07% 28.72%
Merck & Co. Inc. 16.47% 24.77% 19.62% 16.28% 13.51%
Pfizer Inc. 19.47% 25.46% 26.10% 25.92% 22.73%
Regeneron Pharmaceuticals Inc. 42.09% 28.10% 37.77% 35.41% 27.38%
Thermo Fisher Scientific Inc. 24.19% 17.99% 15.53% 14.19% 13.40%
Zoetis Inc. 33.62% 31.42% 31.12% 32.15% 28.48%
Operating Profit Margin, Sector
Pharmaceuticals, Biotechnology & Life Sciences 23.50% 26.64% 24.96% 27.02% 28.63%
Operating Profit Margin, Industry
Health Care 12.21% 14.97% 14.34% 15.46% 16.55%

Based on: 10-K (filing date: 2021-02-17), 10-K (filing date: 2020-02-11), 10-K (filing date: 2019-02-12), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-14).

1 2020 Calculation
Operating profit margin = 100 × Income from operations ÷ Revenue
= 100 × 580 ÷ 3,239 = 17.91%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Illumina Inc.’s operating profit margin ratio improved from 2018 to 2019 but then deteriorated significantly from 2019 to 2020.

Net Profit Margin

Illumina Inc., net profit margin calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 29, 2019 Dec 30, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in millions)
Net income attributable to Illumina stockholders 656  1,002  826  726  463 
Revenue 3,239  3,543  3,333  2,752  2,398 
Profitability Ratio
Net profit margin1 20.25% 28.28% 24.78% 26.38% 19.29%
Benchmarks
Net Profit Margin, Competitors2
AbbVie Inc. 10.08% 23.69% 17.36% 18.82% 23.22%
Amgen Inc. 29.97% 35.32% 37.25% 9.08% 35.27%
Eli Lilly & Co. 25.24% 37.27% 13.16% -0.89% 12.90%
Gilead Sciences Inc. 0.51% 24.35% 25.16% 18.03% 45.07%
Johnson & Johnson 17.82% 18.42% 18.75% 1.70% 23.01%
Merck & Co. Inc. 14.72% 21.01% 14.71% 5.97% 9.85%
Pfizer Inc. 22.95% 31.45% 20.79% 40.55% 13.66%
Regeneron Pharmaceuticals Inc. 41.35% 26.91% 36.42% 20.41% 18.42%
Thermo Fisher Scientific Inc. 19.79% 14.47% 12.06% 10.64% 11.06%
Zoetis Inc. 24.54% 23.96% 24.52% 16.28% 16.80%
Net Profit Margin, Sector
Pharmaceuticals, Biotechnology & Life Sciences 18.06% 24.39% 19.76% 13.79% 21.04%
Net Profit Margin, Industry
Health Care 8.86% 12.75% 10.69% 8.54% 11.60%

Based on: 10-K (filing date: 2021-02-17), 10-K (filing date: 2020-02-11), 10-K (filing date: 2019-02-12), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-14).

1 2020 Calculation
Net profit margin = 100 × Net income attributable to Illumina stockholders ÷ Revenue
= 100 × 656 ÷ 3,239 = 20.25%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Illumina Inc.’s net profit margin ratio improved from 2018 to 2019 but then deteriorated significantly from 2019 to 2020.

Return on Equity (ROE)

Illumina Inc., ROE calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 29, 2019 Dec 30, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in millions)
Net income attributable to Illumina stockholders 656  1,002  826  726  463 
Total Illumina stockholders’ equity 4,694  4,613  3,758  2,749  2,197 
Profitability Ratio
ROE1 13.98% 21.72% 21.98% 26.41% 21.06%
Benchmarks
ROE, Competitors2
AbbVie Inc. 35.30% 104.16% 128.41%
Amgen Inc. 77.20% 81.07% 67.15% 7.84% 25.85%
Eli Lilly & Co. 109.79% 319.09% 32.88% -1.76% 19.54%
Gilead Sciences Inc. 0.68% 23.91% 25.51% 22.64% 71.48%
Johnson & Johnson 23.25% 25.42% 25.60% 2.16% 23.49%
Merck & Co. Inc. 27.91% 37.99% 23.30% 6.97% 9.78%
Pfizer Inc. 15.21% 25.77% 17.59% 29.88% 12.12%
Regeneron Pharmaceuticals Inc. 31.86% 19.08% 27.91% 19.51% 20.13%
Thermo Fisher Scientific Inc. 18.47% 12.45% 10.65% 8.76% 9.39%
Zoetis Inc. 43.46% 55.39% 65.35% 48.81% 55.21%
ROE, Sector
Pharmaceuticals, Biotechnology & Life Sciences 24.50% 35.38% 27.74% 15.79% 23.13%
ROE, Industry
Health Care 15.06% 21.95% 18.53% 13.89% 18.58%

Based on: 10-K (filing date: 2021-02-17), 10-K (filing date: 2020-02-11), 10-K (filing date: 2019-02-12), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-14).

1 2020 Calculation
ROE = 100 × Net income attributable to Illumina stockholders ÷ Total Illumina stockholders’ equity
= 100 × 656 ÷ 4,694 = 13.98%

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. Illumina Inc.’s ROE deteriorated from 2018 to 2019 and from 2019 to 2020.

Return on Assets (ROA)

Illumina Inc., ROA calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 29, 2019 Dec 30, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in millions)
Net income attributable to Illumina stockholders 656  1,002  826  726  463 
Total assets 7,585  7,316  6,959  5,257  4,281 
Profitability Ratio
ROA1 8.65% 13.70% 11.87% 13.81% 10.81%
Benchmarks
ROA, Competitors2
AbbVie Inc. 3.07% 8.84% 9.58% 7.50% 9.01%
Amgen Inc. 11.54% 13.13% 12.64% 2.48% 9.95%
Eli Lilly & Co. 13.28% 21.17% 7.36% -0.45% 7.05%
Gilead Sciences Inc. 0.18% 8.74% 8.57% 6.58% 23.70%
Johnson & Johnson 8.41% 9.59% 10.00% 0.83% 11.71%
Merck & Co. Inc. 7.72% 11.66% 7.53% 2.72% 4.11%
Pfizer Inc. 6.23% 9.72% 7.00% 12.40% 4.20%
Regeneron Pharmaceuticals Inc. 20.47% 14.29% 20.83% 13.67% 12.84%
Thermo Fisher Scientific Inc. 9.23% 6.33% 5.22% 3.93% 4.40%
Zoetis Inc. 12.04% 12.99% 13.25% 10.06% 10.73%
ROA, Sector
Pharmaceuticals, Biotechnology & Life Sciences 7.21% 10.51% 8.83% 5.47% 8.67%
ROA, Industry
Health Care 5.20% 7.67% 6.69% 5.24% 7.31%

Based on: 10-K (filing date: 2021-02-17), 10-K (filing date: 2020-02-11), 10-K (filing date: 2019-02-12), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-14).

1 2020 Calculation
ROA = 100 × Net income attributable to Illumina stockholders ÷ Total assets
= 100 × 656 ÷ 7,585 = 8.65%

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROA A profitability ratio calculated as net income divided by total assets. Illumina Inc.’s ROA improved from 2018 to 2019 but then deteriorated significantly from 2019 to 2020.